Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with breast cancer: results from an interim analysis of the non-interventional study NADIR.

Kurbacher, C., Fietz, T., Trarbach, T., Salat, C., Rezai, M., Lorenz, A., Niemeier, B., 2016.

Ann Oncol (2016) 27 (suppl_6): 1457P. doi:10.1093/annonc/mdw390.25

Studie: NADIR; Indikation: Mammakarzinom; Jahr: 2016; Veranstaltung: ESMO; Journal: Annals of Oncology

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com